Citi Starts Dicerna Pharmaceuticals (DRNA) at Buy
Tweet
Share
E-mailGet Alerts DRNA Hot Sheet
Price: $38.22 --0%
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 6
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 6
Join SI Premium – FREE
Citi analyst Robyn Karnauskas initiates coverage on Dicerna Pharmaceuticals (NASDAQ: DRNA) with a Buy rating and a price target of $27.00.
For an analyst ratings summary and ratings history on Dicerna Pharmaceuticals click here. For more ratings news on Dicerna Pharmaceuticals click here.
Shares of Dicerna Pharmaceuticals closed at $15.43 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Starts Nuvama Wealth Management (NUVAMA:IN) at Buy
- Playtika Holding Corp. (PLTK) PT Lowered to $4.50 at Citi
- Berenberg Starts Raspberry PI Holdings PLC (RPI:LN) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
